Form 4: IQVIA CEO Exercises SARs, Sells Shares for $222.43
Insider Transaction Report
IQVIA Holdings Inc.'s Chairman, CEO, and President, Ari Bousbib, exercised stock appreciation rights and subsequently sold a portion of the acquired common stock.
Summary
- Ari Bousbib, Chairman, Chief Executive Officer & President of IQVIA Holdings Inc., reported transactions on December 18, 2025.
- Exercised 50,000 Stock Appreciation Rights (SARs) at an exercise price of $59.9 per share, which were set to expire on February 2, 2026.
- Following the exercise, 36,564 shares of common stock were sold at a weighted average price of $222.43 per share, with individual transaction prices ranging from $222.28 to $222.79.
- An additional 13,436 shares of common stock were disposed of at $222.91 per share.
- After these transactions, Mr. Bousbib directly owns 807,163 shares of common stock and indirectly owns 543,302 shares through the Orohena Trust.
- The number of derivative securities (Stock Appreciation Rights) beneficially owned after the transaction is 0.
Sentiment
Score: 6
Explanation: The filing details a profitable exercise of stock appreciation rights by a key executive, indicating a positive outcome for the individual's compensation. However, the subsequent sale of shares, while likely for tax or diversification purposes, is generally viewed with neutral to slightly negative sentiment by the market.
Positives
- The executive realized a significant profit by exercising Stock Appreciation Rights at $59.9 and selling shares at prices over $222, indicating a substantial gain on his equity compensation.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-scheduled transaction rather than a reaction to immediate market conditions.
Negatives
- The sale of a significant number of shares by a top executive, even if pre-planned, can sometimes be interpreted by the market as a lack of confidence, though it is often for diversification or tax purposes.
Industry Context
This Form 4 filing is a transactional report detailing insider stock activity and does not provide context on broader industry trends or competitors.
Stakeholder Impact
- Shareholders: May interpret the insider selling as a signal, though the pre-planned nature (Rule 10b5-1) often mitigates negative perceptions. It also highlights the executive's significant personal stake and profitability from equity compensation.
Key Dates
| Date | Description |
|---|---|
| 02/02/2020 | Date Stock Appreciation Rights became exercisable. |
| 12/18/2025 | Transaction date for the exercise of Stock Appreciation Rights and subsequent sale/disposal of common stock. |
| 12/19/2025 | Signature date of the reporting person's attorney-in-fact. |
| 02/02/2026 | Expiration date of the Stock Appreciation Rights. |
Keywords
IQVIA, IQV, Insider Transaction, Form 4, Stock Appreciation Rights, SARs, Executive Compensation, Share Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.